Novo Nordisk
NVO
#14
Rank
โ‚ฌ541.44 B
Marketcap
119,17ย โ‚ฌ
Share price
0.05%
Change (1 day)
36.44%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ8.13 B

According to Novo Nordisk's latest financial reports the company has โ‚ฌ8.13 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31โ‚ฌ4.05 B27.97%
2022-12-31โ‚ฌ3.16 B35.26%
2021-12-31โ‚ฌ2.33 B35.64%
2020-12-31โ‚ฌ1.72 B-16.52%
2019-12-31โ‚ฌ2.06 B-1.2%
2018-12-31โ‚ฌ2.09 B-17.43%
2017-12-31โ‚ฌ2.53 B-9.09%
2016-12-31โ‚ฌ2.78 B1.42%
2015-12-31โ‚ฌ2.74 B28.73%
2014-12-31โ‚ฌ2.13 B10.05%
2013-12-31โ‚ฌ1.93 B-10.25%
2012-12-31โ‚ฌ2.16 B-7.97%
2011-12-31โ‚ฌ2.34 B8.75%
2010-12-31โ‚ฌ2.15 B25.1%
2009-12-31โ‚ฌ1.72 B27.31%
2008-12-31โ‚ฌ1.35 B38.29%
2007-12-31โ‚ฌ0.98 B42.96%
2006-12-31โ‚ฌ0.68 B2.23%
2005-12-31โ‚ฌ0.67 B39.62%
2004-12-31โ‚ฌ0.48 B14.51%
2003-12-31โ‚ฌ0.41 B69.61%
2002-12-31โ‚ฌ0.24 B-51.76%
2001-12-31โ‚ฌ0.51 B155.03%
2000-12-31โ‚ฌ0.20 B7.13%
1999-12-31โ‚ฌ0.18 B88.36%
1998-12-31โ‚ฌ99.62 M-29.1%
1997-12-31โ‚ฌ0.14 B22.89%
1996-12-31โ‚ฌ0.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
โ‚ฌ6.40 B-21.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.03 B-62.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.00 B-26.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.57 B-19.24%๐Ÿ‡ซ๐Ÿ‡ท France